From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Disappointing Results for Lung-Volume–Reduction Surgery

The eagerly awaited National Emphysema Treatment Trial is a randomized multicenter study designed to compare lung-volume–reduction surgery (i.e., resection of 20 percent to 35 percent of each lung) with medical treatment for patients with advanced emphysema. An interim analysis by a data and safety monitoring board has identified a subgroup of patients with excessive mortality after this surgery.

Of 1033 patients enrolled in the trial as of June 2001, 140 patients (70 in the surgery group and 70 in the medical-therapy group) were at high risk by virtue of FEV1 no higher than 20 percent of predicted and either homogeneously distributed emphysema on CT scanning or carbon monoxide diffusing capacity no more than 20 percent of predicted. Thirty-day mortality was 16 percent in the surgery group and 0 percent in the medical-therapy group, a significant difference. Overall mortality also was significantly higher in the surgery group (0.43 vs. 0.11 deaths per person-year). Compared with medically treated patients, those in the lung-volume–reduction group who survived surgery showed some improvement at 6 months in mean maximal workload (P=0.06) and mean distance walked in 6 minutes (P=0.03). However, mean scores for the 2 groups did not differ at 6 months on a health-related quality-of-life index (P=0.94).

Comment: In this trial, a high-risk subgroup of patients did not benefit from lung-volume–reduction surgery: Operative mortality was high, and those who survived experienced unimpressive clinical improvement, according to the authors. The researchers are continuing to enroll patients for this trial, but they are no longer accepting patients with the high-risk characteristics identified in this analysis.

— AS Brett

Published in Journal Watch General Medicine September 25, 2001

Citation(s):

National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume–reduction surgery. N Engl J Med 2001 Oct 11 345 1075-1083.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2001. Massachusetts Medical Society. All rights reserved.